IGF-1 LR3 common uses, half-life, side effects and more

IGF-1 LR3 is a modified version of the growth factor that carries out most of growth hormone's effects. Two changes let it dodge the proteins that normally hold that growth factor in check. It was built as an industrial reagent and is sold to drug makers as an insulin substitute for growing cells in vats. Its own product datasheet says it is not intended for human use. It has never been given to a human in any published study. The company that invented it took three other molecules into clinical trials and never developed this one.

• Muscle gain and body composition (community use)
• Recovery and tissue repair (community use)
• Stacking with growth hormone secretagogues
• Industrial cell culture as its only commercialized use
• Research use in growth and metabolism models

Once daily in community protocols

No validated human dose exists for a compound that has never been given to a human. Community practice is reported at 20 to 100 mcg a day under the skin or into muscle for a few weeks at a time. Those figures have no clinical derivation. Animal studies used continuous infusion rather than daily injection. That difference matters because injection was markedly less effective than infusion where the two were compared. The belief that injecting near a muscle grows that muscle has never been tested with this compound in any species.

No human half-life exists because it has never been given to a human. The widely quoted 20 to 30 hours appears to be a unit error. Natural IGF-1 has a published half-life of 20 to 30 minutes for one of its circulating forms. The claim is also backwards. This analog cleared about ten times faster than natural IGF-1 in rats. Escaping the binding proteins is exactly what shortens a peptide's stay in the blood. The approved natural version has a measured half-life of under six hours.

• Low blood sugar as the most likely acute harm
• Falling levels of the body's own growth hormone and insulin in animal studies
• Lower circulating amino acids in sheep
• Growth of the gut and other internal organs in animals
• No human side effect has ever been recorded because no human has been dosed in a study

IGF-1 LR3 activates the same receptor as natural IGF-1 and drives the same growth pathways. It does not signal differently. Its only edge is that it escapes the binding proteins that normally buffer IGF-1 in the blood. The arginine swap at position three is what does that. The 13-residue tail was added to help bacteria fold the peptide during manufacturing rather than to change how it works. It is actually weaker than natural IGF-1 in cells that make no binding proteins. It also binds the IGF-1 receptor slightly less tightly. Escaping the buffer cuts both ways. Less of it stays in the blood and it clears faster. Far more of what is there is free and active at any moment.

No published study has ever given this compound to a human. There is no human safety data, no human dosing data, and no human pharmacokinetic data. The animal record does not support what it is sold for. It reduced weight gain in finisher pigs and cut their growth hormone peaks by about sixty percent. Natural IGF-1 at the same dose did not impair growth. The reproducible effect in rats and guinea pigs is growth of the gut and other internal organs rather than muscle. No whole-animal study shows it builds muscle in a healthy adult. No study in any species has measured strength.

• It has never been given to a human in any published study so every dose and duration in circulation is guesswork
• Escaping the body's buffering makes low blood sugar worse rather than better and the approved natural version already carries a boxed warning about seizures from severe hypoglycemia
• IGF-1 is the growth signal itself so the cancer concern here is direct rather than extrapolated
• It preserved muscle in tumor-bearing mice while accelerating tumor growth
• A seized black market vial was found to contain a purification-tagged laboratory version rather than an injectable product
• Avoid it in pregnancy and breastfeeding since no human data exist